Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-52.12	8.04	16.79
Graham Fair Price	106.46	28094.51	13607.80
PEG	-86.44	< 0.005	-0.04
Price/Book	-9.23	0.35	0.38
Price/Cash Flow	-89.27	6.41	-59.77
Prices/Earnings	-77.17	1.80	7.90
Price/Sales	-24.75	0.33	0.43
Price/FCF	-89.27	6.41	-59.77
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.38	0.13	0.13
Operating Margin	102.95	0.06	0.03
ROA	311.74	0.02	< 0.005
ROE	0.01	0.05	297.54
ROIC	0.01	0.03	144.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.09	-0.03	-235.03
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.87	1.53	-17.85
EPS QOQ	1.85	3.12	68.35
FCF QOQ	0.75	9.76	1203.95
Revenue QOQ	1.19	0.25	-79.14
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.49	0.47	-5.07
Days Sales Outstanding (DSO)	64.76	51.32	-20.75
Inventory Turnover	182.65	192.40	5.34
Debt/Capitalization	0.34	0.31	-8.77
Quick Ratio	0.97	1.30	33.66
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	26058.51	26983.18	3.55
Cash	15331.78	15686.67	2.31
Capex	-616.79	-435.52	29.39
Free Cash Flow	-166.97	1463.18	776.31
Revenue	23048.07	28786.68	24.90
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.98	1.31	34.25
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.51	3.73	-56.18
Naive Interpretation	Member

06 - Financial Health · Weak

Rating